Bio Valley at AMTZ Wins Prestigious CII – Women in STEM Award
Bio Valley Incubation Council, the Bioincubator arm of the Andhra Pradesh MedTech Zone (AMTZ), is emerging as a key engine powering India’s next generation of healthcare startups. By enabling innovators to transition from laboratory research to market-ready solutions more quickly, safely, and at significantly lower costs, Bio Valley has become a critical pillar of India’s healthcare innovation ecosystem.
In recognition of its impact, Bio Valley Incubation Council has been honoured with the CII Excellence Awards for Women in STEM Award at the CII Global Summit on Technology and R&D for two consecutive years.
Since its inception, Bio Valley has supported over 60 healthcare startups, enabling more than 75 Healthcare products to successfully reach the market. The incubator has facilitated over ₹50 crore through the Seed fund, various schemes of GoI, Investors, and CSR programmes, while actively supporting regulatory approvals, technology transfers and commercialisation pathways that help innovators scale with speed and confidence.
Recognised by the Department of Scientific and Industrial Research (DSIR) and supported by BIRAC under the Bio NEST programme, Bio Valley focuses on high-impact innovation across Diagnostics, In-Vitro diagnostics (IVD), Biologics, Regenerative Medicine, 3D Bioprinting, Biotechnology and convergence Medical Technologies. Spread across over 1 lakh square feet of specialised laboratories and testing facilities, the incubator provides end-to-end support under a single roof, covering design and prototyping, testing, pre-clinical studies, facilitation of regulatory approvals, clinical evaluation and access to manufacturing.
Commenting on the recognition, Dr K. Suseela Branham said, “India’s healthcare innovation ecosystem is at a defining inflexion point. At Bio Valley, our focus is not just
to support innovation, but to systematically convert research into regulatory-ready, scalable and commercially viable healthcare solutions. By providing startups access to advanced infrastructure, regulatory guidance and translational support, we are enabling them to move from concept to market with confidence, speed and global compliance.”
Driving this vision is Dr K. Suseela Branham, CEO of Bio Valley Incubation Council and Head – Biologics & Diagnostics at AMTZ. A public entrepreneur with 19 years of interdisciplinary experience and a recipient of the AAMI Foundation & Institute for Technology in Healthcare Clinical Solution Award 2025, Dr Suseela brings deep expertise across Healthcare operations, Business incubation, Clinical research, Regulatory affairs, and Quality systems spanning Pharma, Medical devices, and Diagnostics. Under her guidance, Bio Valley has become a launchpad for Start-ups to navigate regulatory compliance, risk classification, and market commercialisation efficiently. Her leadership has been instrumental in translating research-driven innovation into scalable, market-ready healthcare solutions
Bio Valley operates as a critical pillar within the larger Andhra Pradesh MedTech Zone (AMTZ), India’s first and largest integrated medical technology manufacturing and innovation ecosystem. Highlighting Bio Valley’s strategic role within the national MedTech ecosystem, Dr Jitendra Sharma, Founder, CEO and Managing Director, AMTZ, said, “Healthcare innovation cannot succeed in isolation.
Startups need access to laboratories, testing, regulatory approvals, clinical validation and funding — all at the same time. Bio Valley was created to remove these barriers completely. Our objective is clear to help Indian innovators build safe, affordable and globally competitive healthcare solutions faster and at scale.”
The incubator also operates four dedicated Centres of Excellence. These include ORGEN, focused on 3D bioprinting and tissue engineering, and an ICMR-supported Animal Research Centre enabling Medical device validation on both Large and Small animal,s is the only Pre-Clinical testing Center in the state of Andhra Pradesh. Bio Valley operates with globally recognised standards of safety and quality, including ISO and GMP certifications, NABL accredited & CDSCO registered In-Vitro Diagnostic Kit Testing and a Biobanking facility which is the nation’s first comprehensive biobank for Diagnostic and advanced research.
Deshbandhu Singh is the Senior Managing Editor at Medical Dialogues and Health Dialogues with about three decades of experience in both print and digital journalism. Previously, he has held editorial leadership roles at NDTV (Head of Digital Content Strategy and Senior Executive Editor), India Today Group Digital, Hindustan Times, Times Internet, and Sahara India. He is known for his expertise in digital content strategy, newsroom operations, and the launch of leading web and mobile platforms in Indian media.